The Medtronic Symplicity Spyral renal denervation catheter in the renal artery, showing how its four electrodes contact the vessel wall for a single RF energy delivery procedure. By ablating the vessel walls, it props the vessel in a fully open position, allowing the kidneys to better filter the blood and remove excess water in hypertension patients. RDN
News | Renal Denervation
Simplicity Renal Denervation Lowered Blood Pressure Out to 3 Years

June 26, 2020 – New data from the Global SYMPLICITY Registry (GSR) showed that renal denervation (RDN) with the ...

Home June 26, 2020
Home
The Foldax Tria surgical valve reimagines the heart valve by incorporating a new, proprietary biopolymer, what the vendor calls LifePolymer, with an innovative valve design intended to eliminate calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants. Tria is also the first heart valve to be robotically manufactured, reducing variability, enabling high precision, repeatability and better quality control.
News | Heart Valve Technology
Foldax Gets $20 Million to Finance Innovative Heart Valve Technology

June 23, 2020 – Heart valve start-up Foldax is looking to reinventing several aspects of the prosthetic heart valve ...

Home June 23, 2020
Home
Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.
News | Defibrillator Monitors
FDA Grants Premarket Clearance for Philips HeartStart FR3 and HeartStart FRx Automated Defibrillators

June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for ...

Home June 23, 2020
Home
Navin Kapur, M.D., Tufts Medical Center, shows preCardia device and its anatomical positioning in the patient to treat heart failure..
News | Heart Failure
FDA Grants Breakthrough Device Designation for preCardia Catheter-based Heart Failure Treatment

June 23, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Program status for the ...

Home June 23, 2020
Home
Signs for "Heroes work here" outside healthcare facilities and even the homes of clinicians have popped up across the country. This photo shows healthcare workers at the Lenox Health emergency room entrance being greeted to cheers and thanks for their essential service during the COVID-19 pandemic in New York City at a public thank you event May 21, 2020. #COVID19 #SARScov2 #pandemic #LenoxHill 
Blog | Coronavirus (COVID-19)
Cardiology Stands Up to the COVID-19 Challenge 

Prior to January 2020 when clinicians read about the history of the 1918 flu, and epidemiologists predicted we were ...

Home June 22, 2020
Home
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts. The company's Hydra TAVR (TAVI) valve gained European CE mark clearance in June 2020.
News | Heart Valve Technology
SMT Enters Structural Heart Market With Acquisition of Vascular Concepts

June 19, 2020 — SMT (Sahajanand Medical Technologies Pvt. Ltd) said it acquired of the structural heart medical device ...

Home June 19, 2020
Home
iVascular Launches Essential Pro Coronary Drug-coated Balloon
News | Drug-Eluting Balloons
iVascular Launches Essential Pro Coronary Drug-coated Balloon

June 19, 2020 — iVascular SLU announced the global launch of Essential Pro, a novel coronary artery drug-coated balloon ...

Home June 19, 2020
Home
MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal coronary angioplasty (PTCA) sirolimus drug-eluting balloon (DEB) for the treatment of coronary artery disease. This includes indications for both de-novo lesions as well as in-stent restenosis. The approval applies to a broad range of balloon sizes, from 1.5 x 10 mm, up to 5 x 40 mm.
News | Drug-Eluting Balloons
MedAlliance Sirolimus Drug Eluting Balloon Gains Second European CE Mark

June 17, 2020 — MedAlliance announced its second CE mark approval for its Selution SLR 0.014 percutaneous transluminal ...

Home June 18, 2020
Home
he 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent showed low rates of revascularization and compared very favorably to current standards of care.  The results were presented by Professor Thomas Zeller, M.D., University Heart Centre Freiburg, Bad Krozingen, Germany at the CX 2020 Live conference.   
News | Peripheral Artery Disease (PAD)
Excellent 3-year Results in MIMICS-2 Study of the BioMimics 3D Vascular Stent 

June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...

Home June 16, 2020
Home
Biotronik Launchs His-Bundle Pacing Tools
News | Pacemakers
Biotronik Launches His-Bundle Pacing Tools

June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...

Home June 16, 2020
Home
Health Canada and the U.S. Food and Drug Administration (FDA) approved Thermedical’s degassed saline for use with its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter, currently being studied for the treatment of ventricular tachycardia (VT), a leading cause of sudden cardiac death worldwide.
News
FDA and Health Canada Approve Thermedical’s Degassed Saline to Help Reduce Risk of Stroke

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine for COVID-19

June 15, 2020 — The U.S. Food and Drug Administration (FDA) today revoked the emergency use authorization (EUA) that ...

Home June 15, 2020
Home
Videos | Heart Valve Technology
VIDEO: Explaining Bicupid Aortic Valves

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

Home June 10, 2020
Home
At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle, and a still micropunture sheath.
Feature | Vascular Access | Dave Fornell, Editor
Use of Ultrasound to Improve Vascular Access

Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access ...

Home June 10, 2020
Home
Centricity Cardio Enterprise[1] is an integrated Cardiovascular PACS (CVPACS) and Information System (CVIS) that bridges the gaps between care areas and healthcare information systems. You get a single point of access for patient data, wave forms, images, analysis tools and physician reports – combined with powerful end-to-end management, analytics and workflow tools across the cardiovascular care pathway.
Webinar | Coronavirus (COVID-19)
WEBINAR: Key Cardiovascular Metrics to Optimize Financial and Operational Outcomes

The financial burden of COVID-19 has put tremendous pressure on health systems across the country. This webinar will ...

Home June 10, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now